NM_001243540.2:c.-99+583A>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001243540.2(CEP295NL):c.-99+583A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.413 in 152,236 control chromosomes in the GnomAD database, including 13,163 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.41 ( 13145 hom., cov: 32)
Exomes 𝑓: 0.40 ( 18 hom. )
Consequence
CEP295NL
NM_001243540.2 intron
NM_001243540.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.276
Publications
7 publications found
Genes affected
CEP295NL (HGNC:44659): (CEP295 N-terminal like) Predicted to enable microtubule binding activity. Predicted to be involved in regulation of centriole replication. Predicted to be located in motile cilium. Predicted to be active in centriole; centrosome; and cytosol. [provided by Alliance of Genome Resources, Apr 2022]
TIMP2 (HGNC:11821): (TIMP metallopeptidase inhibitor 2) This gene is a member of the TIMP gene family. The proteins encoded by this gene family are natural inhibitors of the matrix metalloproteinases, a group of peptidases involved in degradation of the extracellular matrix. In addition to an inhibitory role against metalloproteinases, the encoded protein has a unique role among TIMP family members in its ability to directly suppress the proliferation of endothelial cells. As a result, the encoded protein may be critical to the maintenance of tissue homeostasis by suppressing the proliferation of quiescent tissues in response to angiogenic factors, and by inhibiting protease activity in tissues undergoing remodelling of the extracellular matrix. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.441 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CEP295NL | NM_001243540.2 | c.-99+583A>G | intron_variant | Intron 1 of 2 | ENST00000322630.3 | NP_001230469.1 | ||
| TIMP2 | NM_003255.5 | c.130+22408A>G | intron_variant | Intron 1 of 4 | ENST00000262768.11 | NP_003246.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CEP295NL | ENST00000322630.3 | c.-99+583A>G | intron_variant | Intron 1 of 2 | 2 | NM_001243540.2 | ENSP00000312767.2 | |||
| TIMP2 | ENST00000262768.11 | c.130+22408A>G | intron_variant | Intron 1 of 4 | 1 | NM_003255.5 | ENSP00000262768.6 |
Frequencies
GnomAD3 genomes AF: 0.413 AC: 62817AN: 151932Hom.: 13148 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
62817
AN:
151932
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.398 AC: 74AN: 186Hom.: 18 AF XY: 0.390 AC XY: 53AN XY: 136 show subpopulations
GnomAD4 exome
AF:
AC:
74
AN:
186
Hom.:
AF XY:
AC XY:
53
AN XY:
136
show subpopulations
African (AFR)
AF:
AC:
1
AN:
2
American (AMR)
AF:
AC:
0
AN:
2
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
AC:
0
AN:
4
South Asian (SAS)
AF:
AC:
0
AN:
2
European-Finnish (FIN)
AF:
AC:
2
AN:
4
Middle Eastern (MID)
AF:
AC:
1
AN:
2
European-Non Finnish (NFE)
AF:
AC:
64
AN:
160
Other (OTH)
AF:
AC:
6
AN:
10
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.413 AC: 62838AN: 152050Hom.: 13145 Cov.: 32 AF XY: 0.414 AC XY: 30803AN XY: 74316 show subpopulations
GnomAD4 genome
AF:
AC:
62838
AN:
152050
Hom.:
Cov.:
32
AF XY:
AC XY:
30803
AN XY:
74316
show subpopulations
African (AFR)
AF:
AC:
18522
AN:
41498
American (AMR)
AF:
AC:
5918
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
AC:
1528
AN:
3470
East Asian (EAS)
AF:
AC:
1105
AN:
5166
South Asian (SAS)
AF:
AC:
1644
AN:
4824
European-Finnish (FIN)
AF:
AC:
5007
AN:
10582
Middle Eastern (MID)
AF:
AC:
133
AN:
292
European-Non Finnish (NFE)
AF:
AC:
27768
AN:
67932
Other (OTH)
AF:
AC:
885
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1906
3812
5717
7623
9529
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
594
1188
1782
2376
2970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
904
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.